Scarica l'app Stockscreener
4.98
0.10%
0.02
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
TLSI SEC FilingsTriSalus Life Sciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Exploring TriSalus Life Sciences's Earnings Expectations - Benzinga
Northland Securities Forecasts TLSI FY2025 Earnings - MarketBeat
TLSIW Stock Price, News & Analysis - Stock Titan
TriSalus Life Sciences Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
TLSI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
TriSalus to Raise $40M from Stock Sale - National Today
TLSIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Retail Surge: What are TriSalus Life Sciences Inc Equity Warrants growth levers2025 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
TriSalus Life Sciences (TLSI) to Release Earnings on Thursday - Defense World
TLSI PE Ratio & Valuation, Is TLSI Overvalued - Intellectia AI
TriSalus Life Sciences (NASDAQ: TLSI) raises ~$40M in 9.76M-share offering - Stock Titan
Cancer-focused medtech company TriSalus sets March 5 call on 2025 results - Stock Titan
TriSalus prices $40 mln public stock offering - MSN
TLSI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Insider Buying: David Patience Acquires Shares of TriSalus Life Sciences Inc (TLSI) - GuruFocus
TLSI | TriSalus Life Sciences, Inc. Insider Trading - Quiver Quantitative
TLSI | TriSalus Life Sciences, Inc. FinancialsIncome Statement - Quiver Quantitative
TriSalus Life Sciences (TLSI) CFO adds 3,657 shares in open-market buy - Stock Titan
TriSalus director Gary Gordon buys 9,756 shares (TLSI) in open market - Stock Titan
Director William Valle adds 30,487 TriSalus (TLSI) shares - Stock Titan
TriSalus Life Sciences (TLSI) CEO purchases 30,487 common shares - Stock Titan
TriSalus Life Sciences (TLSI) director adds 361,098 shares in open-market buys - Stock Titan
TriSalus Life Sciences announces plans for public offering - Medical Buyer
TriSalus prices $40M public offering at $4.10 per share By Investing.com - Investing.com South Africa
TriSalus Life Sciences Prices Underwritten Public Equity Offering - TipRanks
TriSalus (TLSI) to raise about $40M in underwritten stock sale - Stock Titan
TriSalus to raise $40M from stock sale - BizWest
TriSalus Life Sciences Prices Stock Offering at $4.10 a Share - marketscreener.com
TriSalus prices $40M public offering at $4.10 per share - Investing.com
Cancer-focused medical tech firm TriSalus raises $40M at $4.10 a share - Stock Titan
Cancer-focused TriSalus Life Sciences plans new stock sale - Stock Titan
Volume Summary: How does TriSalus Life Sciences Inc score in quality rankings2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Risk Hedge: What is TriSalus Life Sciences Inc Equity Warrants P E ratio telling usJuly 2025 Action & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Will TriSalus Life Sciences Inc. benefit from rate cutsEarnings Miss & AI Enhanced Market Trend Forecasts - mfd.ru
Is TriSalus Life Sciences Inc. Equity Warrant forming a bullish divergenceJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - mfd.ru
Published on: 2026-02-14 13:02:33 - mfd.ru
Is TriSalus Life Sciences Inc. Equity Warrant stock a value trapJuly 2025 Update & Entry Point Confirmation Signals - mfd.ru
TriSalus Life Sciences swaps board members - BizWest
Aug Rallies: Is TriSalus Life Sciences Inc Equity Warrants growth already priced inCEO Change & Safe Entry Trade Signal Reports - baoquankhu1.vn
Downgrade Watch: What are the risks of holding TriSalus Life Sciences Inc Equity WarrantJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
How supply chain issues affect TriSalus Life Sciences Inc. Equity Warrant stock2025 Earnings Surprises & Technical Analysis for Trade Confirmation - mfd.ru
Stansky reports major TriSalus (TLSI) stock and warrant holdings on Form 3 - Stock Titan
Investment Review: Is TriSalus Life Sciences Inc Equity Warrant a top pick in the sectorGDP Growth & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Dow Update: Why is TriSalus Life Sciences Inc stock going upGold Moves & Free Accurate Trade Setup Notifications - baoquankhu1.vn
TriSalus Life Sciences appoints Michael Stansky to board of directors By Investing.com - Investing.com South Africa
Trisalus Life Sciences appoints veteran healthcare investor Michael Stansky to its board of directors - marketscreener.com
TriSalus Life Sciences appoints Michael Stansky to board of directors - Investing.com
TriSalus Life Sciences Announces New Board Appointment - TipRanks
40-year healthcare dealmaker joins cancer-tech firm TriSalus board - Stock Titan
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors - marketscreener.com
TriSalus Life Sciences, Inc. Announces Board and Board Committee Changes - marketscreener.com
Trisalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky To Its Board Of Directors - TradingView
TriSalus Life Sciences (NASDAQ:TLSI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Financial Comparison: Phibro Animal Health (NASDAQ:PAHC) & TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Swing Trade: Why is TriSalus Life Sciences Inc stock going upQuarterly Trade Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Trend Report: Is TriSalus Life Sciences Inc Equity Warrant forming a bullish divergence2025 Major Catalysts & Safe Entry Zone Identification - baoquankhu1.vn
Published on: 2026-02-02 19:55:53 - baoquankhu1.vn
Aug Selloffs: Can TriSalus Life Sciences Inc Equity Warrant lead its sector in growthJuly 2025 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
TriSalus Life Sciences (NASDAQ:TLSI) Upgraded at Wall Street Zen - MarketBeat
Head to Head Survey: Semperit Ag Hld (OTCMKTS:SEIGY) & TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Macro Review: What is TriSalus Life Sciences Inc Equity Warrants P E ratio telling usWeekly Volume Report & Comprehensive Market Scan Insights - baoquankhu1.vn
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):